Analytical Data
-
Gene name
ADAMTS19
- Application
-
Alternative Names
ADAM Metallopeptidase With Thrombospondin Type 1 Motif 19
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8TE59
-
Expression Region
Tyr325~Pro686
-
Molecular Weight
44kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ADAMTS19, a member of the ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin Motifs) family, has garnered attention due to its potential roles in various physiological and pathological processes, including extracellular matrix remodeling and cell signaling. This protein is characterized by the presence of multiple thrombospondin type 1 repeats, which are believed to mediate interactions with other extracellular matrix components and influence cellular behaviors. Research has shown that ADAMTS19 may be involved in developmental processes and is expressed in various tissues, suggesting a critical function in maintaining tissue homeostasis. Additionally, alterations in ADAMTS19 expression have been implicated in several conditions, such as fibrosis and cancer progression. The recombinant production of ADAMTS19 offers an invaluable tool for elucidating its biological functions and mechanisms of action. By producing this protein in a controlled environment, researchers can study its enzymatic activity, interaction with substrates, and effects on cellular processes. Understanding the role of ADAMTS19 at a molecular level may provide insights into its therapeutic potential, paving the way for the development of novel treatments for diseases associated with dysregulated extracellular matrix components. Overall, the investigation of ADAMTS19 recombinant protein represents a promising avenue for advancing our knowledge of its function and implications in health and disease.
